SCHEMBL19783467

SCHEMBL19783467

Cc1cc(OCCO)cc2sc(Cl)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.40
MCL1 Q07820 4/20 0.39
TP53 P04637 2/20 0.39
MAPK1 P28482 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA4 P22748 1/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.37
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
BCL2 P10415 2/20 0.36
BCL2L1 Q07817 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19782545 0.86 KMT2A (0.40) CYP1A2POLBCYP2D6TSHRCYP2C19
SCHEMBL30189658 0.86 KMT2A (0.40) CYP1A2POLBCYP2D6TSHRCYP2C19
SCHEMBL10970771 0.84 KMT2A (0.57) CYP1A2POLBCYP2D6TSHRCYP2C19
SCHEMBL30189852 0.79 ALDH1A1 (0.46) CYP1A2CYP2C19KMT2AALDH1A1L3MBTL1
SCHEMBL19782466 0.79 ALDH1A1 (0.46) CYP1A2CYP2C19KMT2AALDH1A1L3MBTL1
SCHEMBL19783614 0.78 KMT2A (0.38) KMT2ACA1CA2CA4ALDH1A1
SCHEMBL30189761 0.76 CA12 (0.44) CA1CA2
SCHEMBL19782882 0.74 KMT2A (0.68) CYP1A2CYP2D6TSHRKMT2ATP53
SCHEMBL19783573 0.73 F2RL3 (0.55)
SCHEMBL28941062 0.73 L3MBTL1 (0.53) KMT2AMAPK1ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689647-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2023-01-20 CN disclosed
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2021-06-03 US disclosed
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BISTOL MYERS SQUIBB COMPANY (US) 2019-09-26 US disclosed
WO-2018013774-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292176-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, PF4 CYP1A2 200/4885POLB 2313/4885CYP2D6 117/4885
US-20210163465-A1 BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS F2, F2RL3, F12 CYP1A2 176/4885POLB 2406/4885CYP2D6 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.